Volume 40 Supplement 1

70th Congress of the Italian Society of Pediatrics

Open Access

Cardiovascular risk prevention in children

  • Francesco Martino1
Italian Journal of Pediatrics201440(Suppl 1):A20

https://doi.org/10.1186/1824-7288-40-S1-A20

Published: 11 August 2014

Cardiovascular disease (CVD) is the major cause of mortality in industrialized countries. Atherosclerosis is characterized by a long lag time between onset and clinical manifestations. There is evidence that CVD initiate before birth by developmental changes in utero. Genetic and environmental factors may interact in specific periods of life (prenatal, perinatal, early childhood), giving rise to altered developmental plasticity and epigenetic modifications with abnormal phenotypic expression of genetic information without altering DNA sequence. Nutritional imbalances and other environmental clues may cause intrauterine growth delay, decreased gestational age, low birth weight and postnatal catch-up growth. Fetal exposure to maternal hypercholesterolemia has been associated with increased risk and progression of atherosclerosis. Oxidative stress seems to play a major role in the atherosclerotic process by activating both platelets and monocytes forming proinflammatory and proaterogenic substances, resulting in endothelial dysfunction, decreased flow-mediated dilation, and increased carotid intima-media thickness [1, 2]. CVD primary prevention should be implemented early. High risk, apparently healthy [3] subjects should be identified , and treated early by healthy eating, physical activity encouragement, healthy lifestyle, the possible addition of nutraceuticals [4] and adding drugs if risk profile is not decreased. Restoration of endothelial function in the reversible phase of atherosclerosis is an essential step. Epigenetics might provide novel and early markers to identify those at risk, thereby developing innovative therapies.

Authors’ Affiliations

(1)
Department of Pediatrics and Child Neuropsychiatry, Sapienza University of Rome

References

  1. Martino F, Pignatelli P, Martino E, Morrone F, Carnevale R, Di Santo S, Buchetti B, Loffredo L, Violi F: Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. J Am Coll Cardiol. 2007, 49: 1974-81. 10.1016/j.jacc.2007.01.082.View ArticlePubMedGoogle Scholar
  2. Martino F, Loffredo L, Carnevale R, Sanguigni V, Martino E, Catasca E, Zanoni C, Pignatelli P, Violi F: Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase. Pediatrics. 2008, 122: e648-55. 10.1542/peds.2008-0735.View ArticlePubMedGoogle Scholar
  3. Martino F, Puddu PE, Pannarale G, Colantoni C, Zanoni C, Martino E, Barillà F: Arterial blood pressure and serum lipids in a population of children and adolescents from Southern Italy: the Calabrian Sierras Community Study (CSCS). Int J Cardiol. 2013, 168: 1108-14. 10.1016/j.ijcard.2012.11.045.View ArticlePubMedGoogle Scholar
  4. Martino F, Puddu PE, Pannarale G, Colantoni C, Martino E, Niglio N, Zanoni C, Zanoni C, Barillà F: Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan. Atherosclerosis. 2013, 228: 198-202. 10.1016/j.atherosclerosis.2013.02.005.View ArticlePubMedGoogle Scholar

Copyright

© Martino; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement